We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FITB
301
Fifth Third Bancorp
FITB
$51.3B
$18.6M 0.07%
678,936
-15,067
-2% -$413K
DLR icon
302
Digital Realty Trust
DLR
$69.6B
$18.6M 0.07%
142,985
+6,513
+5% +$792K
GLW icon
303
Corning
GLW
$107B
$18.5M 0.07%
647,950
-87,734
-12% -$2.63M
B
304
Barrick Mining
B
$60.9B
$18.5M 0.07%
1,066,084
+52,927
+5% +$934K
FTV icon
305
Fortive
FTV
$18B
$18.5M 0.07%
427,170
+87
+0% +$4.01K
ATVI
306
DELISTED
Activision Blizzard
ATVI
$18.3M 0.07%
344,936
+46,146
+15% +$2.3M
TR icon
307
Tootsie Roll Industries
TR
$2.97B
$18.1M 0.07%
600,736
-6,283
-1% -$189K
EQC
308
DELISTED
Equity Commonwealth
EQC
$18.1M 0.07%
528,341
+208,504
+65% +$7.01M
ABB
309
DELISTED
ABB Ltd
ABB
$18M 0.07%
915,093
+11,996
+1% +$229K
CS
310
DELISTED
Credit Suisse Group
CS
$17.8M 0.07%
1,460,651
+229,732
+19% +$2.76M
VOD icon
311
Vodafone
VOD
$37.1B
$17.6M 0.07%
885,877
+343,255
+63% +$6.22M
CIEN icon
312
Ciena
CIEN
$46.8B
$17.6M 0.07%
448,792
-88,899
-17% -$3.73M
PCAR icon
313
PACCAR
PCAR
$70.5B
$17.5M 0.07%
374,870
-8,055
-2% -$367K
CIB icon
314
Grupo Cibest SA
CIB
$21.2B
$17.4M 0.07%
352,280
+38,579
+12% +$1.95M
TDG icon
315
TransDigm Group
TDG
$70.7B
$17.3M 0.07%
33,186
-721
-2% -$370K
SNPS icon
316
Synopsys
SNPS
$71.6B
$17.2M 0.07%
125,636
+3,749
+3% +$507K
DOC icon
317
Healthpeak Properties
DOC
$15.5B
$17.2M 0.07%
483,459
+47,931
+11% +$1.62M
KR icon
318
Kroger
KR
$36.7B
$17M 0.07%
657,746
-225,209
-26% -$5.24M
HPE icon
319
Hewlett Packard
HPE
$58.8B
$16.8M 0.07%
1,109,377
-192,362
-15% -$2.73M
JKHY icon
320
Jack Henry & Associates
JKHY
$11.4B
$16.8M 0.07%
114,827
+8,018
+8% +$1.14M
MCK icon
321
McKesson
MCK
$104B
$16.6M 0.07%
121,445
+8,910
+8% +$1.26M
IQV icon
322
IQVIA
IQV
$40.7B
$16.6M 0.07%
111,091
+4,452
+4% +$693K
APH icon
323
Amphenol
APH
$185B
$16.5M 0.07%
685,752
-52,428
-7% -$1.21M
CP icon
324
Canadian Pacific Kansas City
CP
$81B
$16.4M 0.07%
369,655
+14,400
+4% +$677K
SWK icon
325
Stanley Black & Decker
SWK
$14.5B
$16.4M 0.06%
113,775
-3,552
-3% -$502K

Similar funds

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.